Protect Pharmaceutical Stock Profit Margin
PRTT Stock | USD 0.75 0.05 6.25% |
Protect Pharmaceutical fundamentals help investors to digest information that contributes to Protect Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Protect Pink Sheet. The fundamental analysis module provides a way to measure Protect Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protect Pharmaceutical pink sheet.
Protect |
Protect Pharmaceutical Company Profit Margin Analysis
Protect Pharmaceutical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Protect Pharmaceutical has a Profit Margin of 0.0%. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
All Next | Launch Module |
Protect Fundamentals
Current Valuation | 2.6 M | |||
Shares Outstanding | 1.11 M | |||
Shares Owned By Insiders | 84.30 % | |||
Price To Earning | (23.96) X | |||
EBITDA | (115.4 K) | |||
Net Income | (122.61 K) | |||
Cash And Equivalents | 20.07 K | |||
Total Debt | 101 K | |||
Current Ratio | 0.40 X | |||
Book Value Per Share | (0.01) X | |||
Earnings Per Share | (0.02) X | |||
Number Of Employees | 11 | |||
Beta | 2.38 | |||
Market Capitalization | 2.5 M | |||
Retained Earnings | (9.37 M) | |||
Working Capital | (33 K) | |||
Current Liabilities | 33 K | |||
Z Score | 14.4 |
About Protect Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protect Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protect Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protect Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.